WG
AMAG

Winton Group’s AMAG Pharmaceuticals AMAG Stock Holding History

Winton Group’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-27,033
Closed -$167K – 1650
2020
Q1 		$167K Sell
27,033
-149,731
-85% -$1.32M ﹤0.01% 1277
2019
Q4 		$2.15M Buy
176,764
+150,056
+562% +$1.64M 0.03% 770
2019
Q3 		$308K Buy
+26,708
New +$281K ﹤0.01% 1271

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Winton Group's AMAG Position: Q2 2020 in Review

Winton Group sold out of AMAG Pharmaceuticals (AMAG) in Q2 2020, closing a stake of 27,033 shares — an estimated $167K sold.

Winton Group first reported a position in AMAG in Q3 2019 and held it in 3 quarters. The position peaked at $2.15M in Q4 2019. 119 funds tracked by Wall St. Rank hold AMAG as of Q2 2020.

  • Winton Group reported no remaining AMAG Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Winton Group sold 27,033 AMAG Pharmaceuticals shares in Q2 2020, an estimated $167K.
  • Winton Group first reported a position in AMAG Pharmaceuticals in Q3 2019 and held it in 3 quarters.
  • Winton Group's AMAG Pharmaceuticals position peaked at $2.15M in Q4 2019.
  • 119 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2020.

Based on Winton Group's 13F filing for Q2 2020, filed 5 Aug 2020.